WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) and Employee Benefit Consulting Group LLC (EBCG) announced today the signing of a collaboration agreement to help expand knowledge and potential coverage for Interleukin’s novel genetic risk test, PerioPredict®. PerioPredict® is an innovative, easy-to-use tool that identifies individuals with a higher risk of progressing to severe periodontal disease.
Help employers find you! Check out all the jobs and post your resume.
